Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

You're assuming some senator would have access to confidential FDA reports. This is not likely to be the case.

What is likely to happen is people betting on new biotech issues. This looks like it is what happened. He turned about to right on that occasion.



That's a straw man. The pharma company hadn't even applied for FDA approval yet.


So it was random price action? No catalyst? Then to cry insider trading is beyond absurd.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: